Achieving pain control in early rheumatoid arthritis with baricitinib monotherapy or in combination with methotrexate versus methotrexate monotherapy

<strong>Objectives</strong> This post hoc analysis assessed speed, magnitude and maintenance of pain improvement in patients with early rheumatoid arthritis (RA) receiving baricitinib, baricitinib and methotrexate (MTX), or MTX over 1 year. Cumulative pain and quality of life benefits we...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς: Taylor, P, Alten, R, Álvaro-Gracia, JM, Kaneko, Y, Walls, C, Quebe, A, Jia, B, Bello, N, Terres, JR, Fleischmann, RM
Μορφή: Journal article
Γλώσσα:English
Έκδοση: BMJ Publishing Group 2022